Zealthy Cost: What You Actually Pay Per Month and Per Year

How much does Zealthy actually cost per month, all-in?

Start with the two numbers that matter, because Zealthy bills them separately. The membership is $135 a month. The medication is priced on top of that — compounded semaglutide from $151 a month, compounded tirzepatide from $216 a month. Add them together and a new patient's starting all-in bill runs $286 a month for semaglutide or $351 a month for tirzepatide, before anything else.

That's the real "Zealthy tirzepatide cost" question most people are actually asking: not "what does the drug cost" but "what hits my card each month." $351 is the honest answer at the lowest advertised dose. Zealthy's own pricing page lists $151 and $216 as "as low as" figures tied to a 3-month medication supply — ask directly during intake whether that's the price for paying month to month or only for the prepaid quantity, since the two sources describing it don't fully agree.

What's included in that price, and what's billed separately?

The $135 membership is the part that's easy to miss in an ad built around a discounted first month. It covers your provider visit, unlimited async coaching for dosing and nutrition questions, and — if you go the brand-name route — the team that works your insurance case. It is not a one-time intake fee. It renews every month for as long as you're an active patient, medication or not.

Zealthy frequently discounts that first month to somewhere between $39 and $49, depending on which promo is live when you sign up. That introductory rate is the number most ads lead with, and it is not what you'll pay going forward. Budget against $135, not $39.

• Included in the $135 membership: provider visit and prescribing decision, unlimited async coach messaging, insurance formulary check and prior-authorization filing for the brand-name path
• Billed separately: the medication itself — compounded semaglutide, compounded tirzepatide, or a brand-name drug's cash price if insurance doesn't cover it
• Not clearly included anywhere in Zealthy's public pricing: lab work — if your provider orders baseline bloodwork, confirm in writing whether that's bundled or an add-on before assuming either way
• First-month promo ($39-$49): a one-time introductory rate on the membership only, not a preview of the ongoing price

Does the price go up as your dose increases?

Almost certainly, though Zealthy doesn't say so directly. Both medication prices are advertised with "as low as" language — a phrasing choice that only makes sense if higher tiers cost more. Compounded GLP-1 pharmacies typically charge by drug volume, and a maintenance dose uses meaningfully more volume than a starting dose. Zealthy doesn't publish the full ladder between $151 and whatever the top tier costs, which means the $286 and $351 figures are floors, not averages.

This is the single most important thing to nail down before you enroll: ask your provider, in writing, what your specific starting dose costs and what the next two dose increases would cost. A platform that won't give you that number before you commit is telling you something about how the pricing works.

Compounded semaglutide vs. compounded tirzepatide vs. the brand-name track — which costs less?

Compounded semaglutide is the cheaper entry point at $151 a month on top of membership, and it's the more established of the two molecules — the same GLP-1 mechanism behind Ozempic and Wegovy, just prepared by a compounding pharmacy instead of manufactured as an FDA-reviewed finished drug. Compounded tirzepatide costs $65 a month more, reflecting its dual GIP/GLP-1 mechanism, the same one behind Mounjaro and Zepbound.

The brand-name track is a different kind of bet entirely. Zealthy's coordination team files for insurance coverage on FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro, and advertises a copay as low as $25 a month if your plan says yes. If your plan says no, you're paying that drug's full cash price — which runs well above either compounded tier — on top of the same $135 membership. Treat the $25 figure as a best case, not a starting assumption, until your specific plan's answer comes back.

What's the real annual cost?

Multiplying the starting-dose monthly price by twelve gives a floor, not a forecast: $286 a month for semaglutide comes to roughly $3,432 a year, and $351 a month for tirzepatide comes to roughly $4,212 a year — the range behind Zealthy's own ~$3,400-$4,200/yr estimate. Because Zealthy doesn't publish maintenance-dose pricing, a full year at a higher dose likely lands above that ceiling, possibly well above it.

Labs aren't part of that math. If your provider orders baseline or follow-up bloodwork and it isn't routed through your own primary care provider, a basic metabolic and lipid panel through a direct-pay lab commonly runs somewhere in the $40 to $100 range per draw — a general market figure, not a Zealthy-specific quote, but worth adding to your budget if you're paying for labs out of pocket.

Is there a discount, promo, or cheaper way to pay?

The clearest lever is prepaying a 3-month medication supply, which Zealthy discounts by 20% and pairs with an additional 20% off your next two months of membership. Stack both and the effective monthly cost over that window drops meaningfully below the standalone $286 or $351 figures — though you're committing to three months of medication upfront to get there, with all sales final once a prescription is filled.

Zealthy's pricing page also references discounted quarterly, semi-annual, and annual membership tiers, without listing the exact rate for any of them. If a longer commitment appeals to you, ask for that number in writing before you commit — an unlisted discount isn't a discount you can plan around.

Does insurance or FSA/HSA bring the price down?

Not on the compounded side. Compounded semaglutide and tirzepatide aren't billed to insurance anywhere in this category, Zealthy included — you're paying the $151 or $216 medication price plus membership regardless of what plan you carry. FSA and HSA cards are accepted as a payment method, which can soften the after-tax cost of the membership and medication, though whether your specific plan administrator reimburses a weight-management prescription is worth confirming before you assume it does.

The brand-name track is where insurance actually changes the number. If your plan covers Wegovy, Zepbound, Ozempic, or Mounjaro, Zealthy's coordination team files the prior authorization and a covered copay can run as low as $25 a month — a genuinely different equation from cash-pay compounded pricing. Get your plan's actual answer before counting on it.

Can you cancel anytime, and are there refunds if you stop?

You can cancel anytime by logging into your account and selecting "Manage Membership." Access continues through the end of the billing cycle you've already paid for, with no partial refund for the unused portion. Membership and consultation fees are non-refundable, and once a prescription has been filled, that medication sale is final — there's no refund for a wrong-length supply or a change of mind.

Worth knowing before you prepay a 3-month supply for the discount: some customers report charges continuing after they believed they'd cancelled. Screenshot your cancellation confirmation and check your next statement, rather than assuming the request went through cleanly.

How does Zealthy's total cost compare to Mochi Health, Henry Meds, and Ro?

Mochi Health runs a similar two-part structure — a $79 membership, discounted to $39 the first month — but its medication is now priced per dose rather than flat: compounded semaglutide runs $60 to $99 a month and tirzepatide runs $90 to $199 a month, depending on your prescribed dose. All-in, that's roughly $139 to $178 a month for semaglutide and $169 to $278 a month for tirzepatide — below Zealthy's starting price on both molecules, and its membership alone is $56 a month cheaper.

Henry Meds skips the membership question entirely: one flat, all-in price per format, with no separate charge layered on top. Oral semaglutide runs $249 a month, injectable semaglutide $297, oral tirzepatide $349, and injectable tirzepatide $449 — provider visit, supplies, and shipping included. On tirzepatide specifically, Henry Meds' all-in ceiling sits well above Zealthy's $351 starting price, but there's no separate membership fee to track, and no second subscription to remember to cancel.

Ro doesn't offer a compounded option at all — every medication on its menu is FDA-approved brand-name Wegovy or Zepbound, dispensed through manufacturer partnerships. Its $149 membership (discounted to $39 the first month) sits on top of medication that, paid in cash, runs roughly $298 to $448 a month for oral Wegovy or $548 to $598 a month for Zepbound. That's a real premium over Zealthy's compounded tiers, but it buys an FDA-reviewed finished drug rather than a compounded one — which is close to what Zealthy's own brand-name track is trying to offer, minus the compounded fallback option.

The short version: on starting-dose compounded pricing alone, Mochi is cheaper than Zealthy on both molecules, Henry Meds is cheaper on semaglutide but pricier on tirzepatide, and Ro is pricier across the board because it doesn't compound at all. Zealthy's real differentiator isn't being the lowest bill — it's having both a compounded floor and a brand-name/insurance path under one account.

Is the price worth it given the pending DOJ billing lawsuit?

It's a fair question to ask specifically on a cost page, because the DOJ and FTC's case against Zealthy centers on billing practices — hiding subscription terms, making cancellation difficult, and, per an April 2026 amended complaint, an emergency motion asking the court to freeze the company's assets over its financial exposure in the case. None of that has been decided in court as of this writing, and it doesn't make the underlying medical care fake. But it's a reasonable factor to weigh specifically before you prepay for a 3-month supply or commit to a longer membership term, since a receivership could affect ongoing service in ways a month-to-month commitment wouldn't. The full legal picture, including the FDA warning letter and customer complaint pattern, is in the complete Zealthy review.